Annual Long Term Debt
$53.08 M
-$8.42 M-13.68%
December 31, 2023
Summary
- As of February 26, 2025, SYRS annual long term debt is $53.08 million, with the most recent change of -$8.42 million (-13.68%) on December 31, 2023.
- During the last 3 years, SYRS annual long term debt has fallen by -$11.40 million (-17.68%).
- SYRS annual long term debt is now -17.68% below its all-time high of $64.48 million, reached on December 31, 2020.
Performance
SYRS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$57.64 M
-$524.00 K-0.90%
September 30, 2024
Summary
- As of February 26, 2025, SYRS quarterly long term debt is $57.64 million, with the most recent change of -$524.00 thousand (-0.90%) on September 30, 2024.
- Over the past year, SYRS quarterly long term debt has stayed the same.
- SYRS quarterly long term debt is now -10.61% below its all-time high of $64.48 million, reached on December 31, 2020.
Performance
SYRS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
SYRS Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.7% | 0.0% |
| 3 y3 years | -17.7% | -3.0% |
| 5 y5 years | +10000.0% | -3.0% |
SYRS Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.0% | at low | -8.8% | +21.1% |
| 5 y | 5-year | -17.7% | +115.5% | -10.6% | +133.9% |
| alltime | all time | -17.7% | -100.0% | -10.6% | >+9999.0% |
Syros Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $57.64 M(-0.9%) |
| Jun 2024 | - | $58.17 M(+22.2%) |
| Mar 2024 | - | $47.59 M(-10.3%) |
| Dec 2023 | $53.08 M(-13.7%) | $53.08 M(-9.3%) |
| Sep 2023 | - | $58.55 M(-3.5%) |
| Jun 2023 | - | $60.66 M(+2.1%) |
| Mar 2023 | - | $59.41 M(-3.4%) |
| Dec 2022 | $61.50 M(-2.7%) | $61.50 M(-0.6%) |
| Sep 2022 | - | $61.90 M(+10.8%) |
| Jun 2022 | - | $55.86 M(-8.7%) |
| Mar 2022 | - | $61.16 M(-3.2%) |
| Dec 2021 | $63.18 M(-2.0%) | $63.18 M(-0.5%) |
| Sep 2021 | - | $63.53 M(-0.5%) |
| Jun 2021 | - | $63.85 M(-0.5%) |
| Mar 2021 | - | $64.17 M(-0.5%) |
| Dec 2020 | $64.48 M | $64.48 M(+42.9%) |
| Sep 2020 | - | $45.11 M(-0.8%) |
| Jun 2020 | - | $45.47 M(+2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $44.37 M(+80.1%) |
| Dec 2019 | $24.64 M(>+9900.0%) | $24.64 M(+29.2%) |
| Sep 2019 | - | $19.07 M(+12.5%) |
| Jun 2019 | - | $16.95 M(+1007.4%) |
| Mar 2019 | - | $1.53 M(+6859.1%) |
| Dec 2018 | $22.00 K(+266.7%) | $22.00 K(-8.3%) |
| Sep 2018 | - | $24.00 K(-11.1%) |
| Jun 2018 | - | $27.00 K(+440.0%) |
| Mar 2018 | - | $5000.00(-16.7%) |
| Dec 2017 | $6000.00(-88.7%) | $6000.00(-14.3%) |
| Sep 2017 | - | $7000.00(-12.5%) |
| Jun 2017 | - | $8000.00(-11.1%) |
| Mar 2017 | - | $9000.00(-83.0%) |
| Dec 2016 | $53.00 K(-74.3%) | $53.00 K(-44.8%) |
| Sep 2016 | - | $96.00 K(-30.4%) |
| Jun 2016 | - | $138.00 K(-16.9%) |
| Mar 2016 | - | $166.00 K(-19.4%) |
| Dec 2015 | $206.00 K(>+9900.0%) | $206.00 K |
| Dec 2014 | $0.00 | - |
FAQ
- What is Syros Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual long term debt year-on-year change?
- What is Syros Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly long term debt year-on-year change?
What is Syros Pharmaceuticals annual long term debt?
The current annual long term debt of SYRS is $53.08 M
What is the all time high annual long term debt for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual long term debt is $64.48 M
What is Syros Pharmaceuticals annual long term debt year-on-year change?
Over the past year, SYRS annual long term debt has changed by -$8.42 M (-13.68%)
What is Syros Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of SYRS is $57.64 M
What is the all time high quarterly long term debt for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly long term debt is $64.48 M
What is Syros Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, SYRS quarterly long term debt has changed by $0.00 (0.00%)